04/12/2024 3:22 PM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2024 7:13 PM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:57 PM | LALANDE KEVIN M. (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 8:56 PM | Molecular Templates (Subject) SANTE HEALTH VENTURES I LP (Filed by)
| Form SC 13D/A | |
03/29/2024 3:06 PM | Molecular Templates (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024 7:57 AM | Molecular Templates (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/29/2024 7:45 AM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
03/28/2024 7:22 AM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 3:08 PM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:39 PM | Molecular Templates (Subject) SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
02/14/2024 3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by) Molecular Templates (Subject)
| Form SC 13G/A | |
02/14/2024 8:33 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Molecular Templates (Subject)
| Form SC 13G/A | |
02/13/2024 10:00 AM | BB BIOTECH AG (Filed by) Molecular Templates (Subject)
| Form SC 13G/A | |
01/25/2024 4:32 PM | Molecular Templates (Issuer) Poma Eric E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 4:34 PM | Kim Jason S. (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 4:49 PM | Molecular Templates (Issuer) Voi Maurizio (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 5:45 PM | LALANDE KEVIN M. (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 5:46 PM | Lanfear Jonathan (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 5:46 PM | Molecular Templates (Issuer) Sanders Corazon D. (0001796536) (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 5:46 PM | Molecular Templates (Issuer) SELICK HAROLD E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 5:45 PM | Gruia Gabriela (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/31/2023 5:45 PM | HOFFMANN DAVE (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/27/2023 3:12 PM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 4:08 PM | Molecular Templates (Issuer) Voi Maurizio (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/28/2023 4:01 PM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2023 4:08 PM | Molecular Templates (Filer)
| Form DEF 14A | |
09/12/2023 4:12 PM | Molecular Templates (Filer)
| Form DEFA14A | |
09/12/2023 4:15 PM | Molecular Templates (Filer)
| Form ARS | |
08/31/2023 5:22 PM | Gruia Gabriela (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2023 11:15 PM | Molecular Templates (Filer)
| Form EFFECT | |
08/10/2023 8:01 AM | Molecular Templates (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/10/2023 7:18 AM | Molecular Templates (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 7:09 AM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/20/2023 4:09 PM | LYTTON LAURENCE W (Filed by) Molecular Templates (Subject)
| Form SC 13G | |
07/19/2023 2:14 PM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Molecular Templates (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2023 2:05 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Molecular Templates (Subject)
| Form SC 13G | |
07/18/2023 10:56 AM | Molecular Templates (Filer)
| Form DEF 14A | |
07/13/2023 11:48 AM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 3:31 PM | Molecular Templates (Filer)
| Form PRE 14A | |
06/26/2023 4:27 PM | K2 HealthVentures Equity Trust LLC (Filed by) Molecular Templates (Subject)
| Form SC 13G | |
06/20/2023 6:00 AM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
06/01/2023 6:59 AM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/26/2023 4:16 PM | Molecular Templates (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2023 6:31 AM | Molecular Templates (Filer)
| Form 10-K/A | |